SEC Form 4 · accession 0001209191-16-129947
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Vander Vort
Director
Period of report
Jun 26, 2013
Accepted (ET)
Jun 28, 2016 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2016 | A | 4,500 | $0.00 | A | 29,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.00 | Jun 26, 2013 | A | 13,237 | A | — | Jun 26, 2023 | Common Stock | 13,237 | 13,237 | D |
| Stock Option (Right to Buy)F2 | $6.12 | Jun 24, 2016 | A | 7,500 | A | — | Jun 23, 2026 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1Vests in four substantially equal installments on each of the first four anniversaries of the grant date, subject to continued service as a member of the Board of Directors of the Issuer through the applicable vesting dates.
- F2Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date.